|
RNF14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.91880000064171E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.9560999981193E-08 |
| Normal-vs-Stage2 |
4.489200E-01 |
| Normal-vs-Stage3 |
8.80490003130063E-09 |
| Normal-vs-Stage4 |
2.33840002916708E-09 |
| Stage1-vs-Stage2 |
3.060100E-03 |
| Stage1-vs-Stage3 |
2.402400E-01 |
| Stage1-vs-Stage4 |
4.424300E-02 |
| Stage2-vs-Stage3 |
7.203700E-04 |
| Stage2-vs-Stage4 |
9.96220000000214E-05 |
| Stage3-vs-Stage4 |
2.926800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.0746004913974E-10 |
| Normal-vs-AfricanAmerican |
1.559440E-03 |
| Normal-vs-Asian |
1.81590000003506E-06 |
| Caucasian-vs-AfricanAmerican |
4.587000E-01 |
| Caucasian-vs-Asian |
9.501800E-01 |
| AfricanAmerican-vs-Asian |
5.001600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.76659999999918E-05 |
| Normal-vs-Female |
1.93639999590545E-08 |
| Male-vs-Female |
3.951000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.49549999553622E-08 |
| Normal-vs-Age(41-60Yrs) |
4.23110000036253E-07 |
| Normal-vs-Age(61-80Yrs) |
1.598210E-04 |
| Normal-vs-Age(81-100Yrs) |
2.048400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.367200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.685630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.919400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.550800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.578600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.383400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.508200E-01 |
| Classical-VS-Follicular |
6.69409999654036E-08 |
| Classical-VS-Other |
8.252000E-01 |
| Classical-VS-Normal |
1.52770018857495E-10 |
| Tall-VS-Follicular |
2.39979999983042E-07 |
| Tall-VS-Other |
7.793200E-01 |
| Tall-VS-Normal |
1.7654000039613E-08 |
| Follicular-VS-Other |
5.539600E-02 |
| Follicular-VS-Normal |
4.433600E-01 |
| Other-VS-Normal |
7.122400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.366100E-04 |
| Normal-vs-N1 |
5.53729950780735E-10 |
| N0-vs-N1 |
1.960600E-04 |
|
|
